Speaker illustration

Associate Professor Asparuh Nikolov

Medical University Pleven, Pleven (Bulgaria)

Dr. Nikolov graduated from Medical University Pleven, Bulgaria in 2009. His tasks are management of people with cardiovascular diseases and dyslipidemia research. More than 60% of his patients are with dyslipidemia. Atherosclerosis is one of the major characteristics of the population with essential hypertension and a key risk factor underlying pathogenesis of ischamic heart disease. From 2009 to 2016 Dr. Nikolov was an assistant professor in Clinic of Internal Medicine, University Hospital, Pleven, Bulgaria. Currently, he is an associated professor of Cardiology and Member of Cardiovascular Disease Study Group in Institute for Scientific Research in Medical University Pleven. His research focuses on investigation of the immunological aspects of normal and pathological connective tissue turnover in patients with atherosclerosis, hypertension and heart failure. Dr. Nikolov compies both scientific and clinical work in the fields of Cardiology, Atherosclerosis and Cardiovascular research

Levels of anti-elastin IgA antibodies are associated with high risk of atherosclerosis in diabetics with essential hypertension

Event: Frontiers in CardioVascular Biology 2018

Topic: Biomarkers

Session: Basic Science - Cardiac Diseases

Thumbnail

Serum levels of elastin derived peptides and circulating elastin-antielastin immune complexes in sera of patients with coronary artery disease

Event: Frontiers in CardioVascular Biology 2016

Topic: Fibroblasts / Fibrosis / Matrix

Session: Extracellular matrix and fibrosis - Heart

Thumbnail

Atherogenic indices, collagen type IV turnover and the development of microvascular complications- study in diabetics with arterial hypertension

Event: Frontiers in CardioVascular Biology 2016

Topic: Microcirculation

Session: Microcirculation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb